Correlation Between Innate Pharma and Adocia
Can any of the company-specific risk be diversified away by investing in both Innate Pharma and Adocia at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Innate Pharma and Adocia into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Innate Pharma and Adocia, you can compare the effects of market volatilities on Innate Pharma and Adocia and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Innate Pharma with a short position of Adocia. Check out your portfolio center. Please also check ongoing floating volatility patterns of Innate Pharma and Adocia.
Diversification Opportunities for Innate Pharma and Adocia
-0.43 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Innate and Adocia is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Innate Pharma and Adocia in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adocia and Innate Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Innate Pharma are associated (or correlated) with Adocia. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adocia has no effect on the direction of Innate Pharma i.e., Innate Pharma and Adocia go up and down completely randomly.
Pair Corralation between Innate Pharma and Adocia
Assuming the 90 days trading horizon Innate Pharma is expected to generate 0.8 times more return on investment than Adocia. However, Innate Pharma is 1.25 times less risky than Adocia. It trades about -0.01 of its potential returns per unit of risk. Adocia is currently generating about -0.19 per unit of risk. If you would invest 194.00 in Innate Pharma on December 30, 2024 and sell it today you would lose (8.00) from holding Innate Pharma or give up 4.12% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Innate Pharma vs. Adocia
Performance |
Timeline |
Innate Pharma |
Adocia |
Innate Pharma and Adocia Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Innate Pharma and Adocia
The main advantage of trading using opposite Innate Pharma and Adocia positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Innate Pharma position performs unexpectedly, Adocia can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adocia will offset losses from the drop in Adocia's long position.Innate Pharma vs. Genfit | Innate Pharma vs. Nanobiotix SA | Innate Pharma vs. Cellectis | Innate Pharma vs. AB Science SA |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Complementary Tools
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |